DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells

23Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

DNA damage-induced apoptosis suppressor (DDIAS) regulates cancer cell survival. Here we investigated the involvement of DDIAS in IL-6–mediated signaling to understand the mechanism underlying the role of DDIAS in lung cancer malignancy. We showed that DDIAS promotes tyrosine phosphorylation of signal transducer and activator of transcription 3 (STAT3), which is constitutively activated in malignant cancers. Interestingly, siRNA protein tyrosine phosphatase (PTP) library screening revealed protein tyrosine phosphatase receptor mu (PTPRM) as a novel STAT3 PTP. PTPRM knockdown rescued the DDIAS-knockdown-mediated decrease in STAT3 Y705 phosphorylation in the presence of IL-6. However, PTPRM overexpression decreased STAT3 Y705 phosphorylation. Moreover, endogenous PTPRM interacted with endogenous STAT3 for dephosphorylation at Y705 following IL-6 treatment. As expected, PTPRM bound to wild-type STAT3 but not the STAT3 Y705F mutant. PTPRM dephosphorylated STAT3 in the absence of DDIAS, suggesting that DDIAS hampers PTPRM/STAT3 interaction. In fact, DDIAS bound to the STAT3 transactivation domain (TAD), which competes with PTPRM to recruit STAT3 for dephosphorylation. Thus we show that DDIAS prevents PTPRM/STAT3 binding and blocks STAT3 Y705 dephosphorylation, thereby sustaining STAT3 activation in lung cancer. DDIAS expression strongly correlates with STAT3 phosphorylation in human lung cancer cell lines and tissues. Thus DDIAS may be considered as a potential biomarker and therapeutic target in malignant lung cancer cells with aberrant STAT3 activation.

References Powered by Scopus

STATs in cancer inflammation and immunity: A leading role for STAT3

3582Citations
N/AReaders
Get full text

Sulforhodamine B colorimetric assay for cytotoxicity screening

3079Citations
N/AReaders
Get full text

Stat3 as an oncogene

2614Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Multicellular effects of stat3 in non-small cell lung cancer: Mechanistic insights and therapeutic opportunities

34Citations
N/AReaders
Get full text

Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer

31Citations
N/AReaders
Get full text

PTPRM methylation induced by FN1 promotes the development of glioblastoma by activating STAT3 signalling

14Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Im, J. Y., Kim, B. K., Lee, K. W., Chun, S. Y., Kang, M. J., & Won, M. (2020). DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells. Oncogenesis, 9(1). https://doi.org/10.1038/s41389-019-0187-2

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

56%

Researcher 3

33%

Professor / Associate Prof. 1

11%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 6

55%

Agricultural and Biological Sciences 2

18%

Medicine and Dentistry 2

18%

Pharmacology, Toxicology and Pharmaceut... 1

9%

Save time finding and organizing research with Mendeley

Sign up for free